Position in HRMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,747,135
+$469,825 QoQ
Shares Held
102,915
-12.0% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 328 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. HRMY ranks #66 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in HRMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,747,135 | 102,915 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,277,310 | 117,005 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,375,445 | 116,928 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,389,576 | 122,989 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,766,751 | 119,201 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,620,132 | 109,073 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,736,513 | 108,588 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,682,040 | 92,051 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,037,937 | 100,694 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,496,181 | 104,115 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,247,603 | 100,545 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,355,025 | 102,381 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,338,334 | 94,866 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,757,031 | 84,442 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,401,663 | 79,885 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,519,814 | 79,472 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,238,181 | 66,397 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,884,507 | 59,291 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,285,034 | 53,589 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $770,318 | 20,097 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $536,370 | 19,000 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||